Open AccessGlobal Biosimilar Drug Development: Any Chance for Consolidation after 15 Years of Positive Regulatory Experience?
Author(s) -
Zsolt Holló
Publication year - 2021
Publication title -
acta pharmaceutica hungarica
Language(s) - English
Resource type - Journals
eISSN - 1587-1495
pISSN - 0001-6659
DOI - 10.33892/aph.2021.91.138-139
Subject(s) - biosimilar , consolidation (business) , drug development , drug , business , medicine , pharmacology , accounting